The statement confirms that the FDA has given NWBO no feedback that the P3 trial will be approvable.
First, we were talking about the SAP.
Second, this statement confirms nothing. The FDA is in constant contact with the trial sponsors to work with them on a myriad of issues. This narrative shows a complete lack of understand of the FDA process.